Alpha toxin from Clostridium pefringens induces proinflammatory changes in endothelial cells

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 565-574

  Bunting, Michaeline ^a,b   Lorant, Diane E ^b   Bryant, Amy E ^c   Zimmerman, Guy A ^b   McIntyre, Thomas M ^b   Stevens, Dennis L ^c   Prescott, Stephen M ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Boise VA Medical Center   (United States)

Author keywords

Cell adhesion; Endothelium; Epoprostenol; Phospholipase C; Platelet activating factor

Indexed keywords

ALPHA TOXIN; CERAMIDE; CLOSTRIDIUM TOXIN; DIACYLGLYCEROL KINASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; PADGEM PROTEIN; PHOSPHOLIPASE C; PROSTACYCLIN; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BACTERIAL INFECTION; CELL ADHESION; CLOSTRIDIUM PERFRINGENS; ENDOTHELIUM CELL; ENZYME ACTIVITY; GAS GANGRENE; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TOXIN ANALYSIS;

EID: 0030854109     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119566     Document Type: Article

References (51)

1. MacLennan, J.D. 1962. The histotoxic clostridial infections of man. Bacteriol. Rev. 26:177-276.
2. Robb-Smith, A.H.T. 1945. Tissue changes induced by Cl. welchii type A filtrates. Lancet. 362-368.
3. Kameyama, S., H. Sato, and R. Murata. 1972. The role of α-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs. Jpn. J. Med. Sci. Biol. 25:200.
4. Williamson, E.D., and R.W. Titball. 1993. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine. 11:1253-1258.
5. Awad, M.M., A.E. Bryant, D.L. Stevens, and J.I. Rood. 1995. Virulence studies on chromosomal α-toxin and θ-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α-toxin in Clostridium perfringens-mediated gas gangrene. Mol. Microbiol. 15:191-202.
6. Macfarlane, M. G. 1948. The biochemistry of bacterial toxins. Biochem J. 42:587-590.
7. Macfarlane, M.G., and B.C.J.G. Knight. 1941. The biochemistry of bacterial toxins. Biochem. J. 35:884-902.
8. Tso, J.Y., and C. Siebel. 1989. Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans. Infect. Immun. 57:468-476.
9. Titball, R.W., S.E.C. Hunter, K.L. Martin, B.C. Morris, A.D. Shuttleworth, T. Rubidge, D.W. Anderson, and D.C. Kelly. 1989. Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens. Infect. Immun. 57:367-376.
10. Leslie, D., N. Fairweather, D. Pickard, G. Dougan, and M. Kehoe. 1989. Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli: sequence and homology with a Bacillus cereus phospholipase C. Mol. Microbiol. 3:383-392.
11. Okabe, A., T. Shimizu, and H. Hayashi. 1989. Cloning and sequencing of a phospholipase C gene of Clostridium perfringens. Biochem. Biophys. Res. Commun. 160:33-39.
12. Zimmerman, G.A., T.M. McIntyre, and S.M. Prescott. 1985. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 76:2235-2246.
13. 4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl. Acad. Sci. USA. 83:2204-2208.
14. Geng, J.G., M.P. Bevilacqua, K.L. Moore, T.M. McIntyre, S.M. Prescott, J.M. Kim, G.A. Bliss, G.A. Zimmerman, and R.P. McEver. 1990. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (Lond.). 343:757-760.
15. Lorant, D.E., K.D. Patel, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman. 1991. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin. A juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115:223-234.
16. Lorant, D.E., M.K. Topham, R.E. Whatley, R.P. McEver, T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 1993. Inflammatory roles of P-selectin. J. Clin. Invest. 92:559-570.
17. Zimmerman, G.A., T.M. McIntyre, M. Mehra, and S.M, Prescott. 1990. Endothelial cell-associated platelet-activating factor. A novel mechanism for signaling intercellular adhesion. J. Cell Biol. 110:529-540.
18. Stafforini, D.M., S.M. Prescott, and T.M. McIntyre. 1987. Human plasma platelet-activating factor acetylhydrolase: purification and properties. J. Biol. Chem. 262:4223-4230.
19. Sato, H., J. Chiba, and Y. Sato. 1989. Monoclonal antibodies against alpha-toxin of Clostridium perfringens. FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett. 59:173-176.
20. Stevens, D.L., J. Mitten, and C. Henry. 1987. Effects of α and θ toxins from Clostridium perfringens on human polymorphonuclear leukocytes. J. Infect. Dis. 156:324-333.
21. Bryant, A.E., and D.L. Stevens. 1996. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect. Immun. 64:358-362.
22. Zimmerman, G.A., R.E. Whatley, T.M. McIntyre, D.M. Benson, and S.M. Prescott. 1990. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites. Methods Enzymol. 187:520-535.
23. McIntyre, T.M., G.A. Zimmerman, K. Satoh, and S.M. Prescott. 1985. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J. Clin. Invest. 76:271-280.
24. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
25. Preiss, J., C.R. Loomis, W.R. Bishop, R. Stein, J.E. Niedel, and R.M. Bell. 1986. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:8597-8600.
26. Mulligan, M.S., M.J. Polley, R.J. Bayer, M.F. Nunn, J.C. Paulson, and P.A. Ward. 1992. Neutrophil-dependent acute lung injury. J. Clin. Invest. 90: 1600-1607.
27. Patel, K.D., G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre. 1992. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J. Biol. Chem. 267:15168-15175.
28. Mueller, H.W., J.T. O'Flaherty, and R.L. Wykle. 1983. Biosynthesis of platelet-activating factor in rabbit polymorphonuclear neutrophils. J. Biol. Chem. 258:6213-6218.
29. Prescott, S.M., G.A. Zimmerman, and T.M. McIntyre. 1984. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. USA. 81:3534-3538.
30. Johnson, R.A., D.R. Morton, J.H. Kinner, R.R. Gorman, J.C. McGuire, and F.F. Sun. 1976. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 12:915-928.
31. Whatley, R.E., G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott. 1990. Lipid metabolism and signal transduction in endothelial cells. Prog. Lipid Res. 29:45-63.
32. Whatley, R.E., P. Nelson, G.A. Zimmerman, D.L. Stevens, C.J. Parker, T.M. McIntyre, and S.M. Prescott. 1989. The regulation of platelet-activating factor production in endothelial cells. J. Biol. Chem. 264:6325-6333.
33. Lorant, D.E., G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott. 1995. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin. Cell Biol. 6:295-303.
34. Stevens, D.L., B.E. Troyer, D.T. Merrick, J.E. Mitten, and R.D. Olson. 1988. Lethal effects and cardiovascular effects of purified α- and θ-toxins from Clostridium perfringens. J. Infect. Dis. 157:272-279.
35. Dalldorf, F.G., C.N. Carney, C.E. Rackley, and R.B. Raney. 1968. Pulmonary capillary thrombosis in septicemia due to gram-positive bacteria. JAMA (J. Am. Med. Assoc.). 206:583-586.
36. Macfarlane, R.G., and J.D. MacLennan. 1945. The toxemia of gas-gan-grene. Lancet. 328-331.
37. Benveniste, J., J.P. Le Couedic, and P. Kamoun. 1975. Letter: Aggregation of human platelets by platelet-activating factor. Lancet. 344-345.
38. O'Flaherty, J.T., R.L. Wykle, C.H. Miller, J.C. Lewis, M. Waite, D.A. Bass, C.E. McCall, and L.R. DeChatelet. 1981. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines. Am. J. Pathol. 103:70-79.
39. Hayashi, H., I. Kudo, K. Inoue, H. Nomura, and S. Nojima. 1985. Macrophage activation by PAF incorporated into dipalmitoylphosphatidylcholine-cholesterol liposomes. J. Biochem. 97:1255-1258.
40. Bjork, J., L. Lindbom, B. Gerdin, G. Smedegard, K.E. Arfors, and J. Benveniste. 1983. Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. Acta. Physiol. Scand. 119:305-308.
41. Humphrey, D.M., L.M. McManus, D.J. Hanahan, and R.N. Pinckard. 1984. Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab. Invest. 50:16-25.
42. Holland, M.R., T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott. 1991. Cardiovascular effecls of platelet-activating factor. Trends. Cardiovasc. Med. 1:117-121.
43. Levi, R., J.A. Burke, Z.G. Guo, Y. Hattori, CM. Hoppens, L.M. McManus, D.J. Hanahan, and R.N. Pinckard. 1984. Acetyl glyceryl ether phosphorylcholine (AGEPC). Circ. Res. 54:117-124.
44. McManus, L.M., D.S. Woodard, S.J. Deavers, and R.N. Pinckard. 1993. Biology of disease. Lab. Invest. 69:639-650.
45. Modur, V., G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre. 1996. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 271:13094-13102.
46. Sugahara, T., T. Takahashi, S. Yamaya, and A. Ohsaka. 1977. Vascular permeability increase by α-toxin (phospholipase C) of Clostridium perfringens. Toxicon. 15:81-87.
47. Yao, B.L., J. Pan, H. Setiadi, K.D. Patel, and R.P. McEver. 1996. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med. 184:81-92.
48. Moncada, S., R. Gryglewski, S. Bunting, and J.R. Vane. 1976. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (Lond.). 263:663-665.
49. Chilton, F.H., J.M. Ellis, S.C. Olson, and R.L. Wykle. 1984. 1-O-Alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J. Biol. Chem. 259:12014-12019.
50. Ramesha, C.S., and W.C. Pickett. 1986. Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J. Biol. Chem. 261:7592-7595.
51. Gill, E.A., T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 1992. Mechanisms of vascular injury in the pathogenesis of infectious disease. Curr. Opin. Infect. Dis. 5:381-388.